What is the Impact Factor of Journal of Chemotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Chemotherapy is 2.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Journal of Chemotherapy indexed in Web of Science or Scopus?

Yes, Journal of Chemotherapy is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.525 (Q3) and an H-index of 60.

Who publishes Journal of Chemotherapy and what is the Article Processing Charge (APC)?

Journal of Chemotherapy is published by Maney Publishing. The estimated Article Processing Charge (APC) is approximately $2,876 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Chemotherapy?

The official ISO-4 abbreviation of Journal of Chemotherapy is "J. Chemother" with common acronym "joc". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #11,349Hybrid

Journal of Chemotherapy

Acronym:joc

•

Abbreviation (ISO):J. Chemother

•

Identifier (ISSN):1120-009X(Print)/1973-9478(Online)

•

Publisher:Maney Publishing

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Chemotherapy

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q3

0.525

#11,349

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

60 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

74articles/year

4.68% Gold OA•85.19% Original Research

Aims & Scope

The Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research on all aspects of antimicrobial and antitumor chemotherapy. The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs. Specific areas of focus include, but are not limited to: · Antibacterial, antiviral, antifungal, antiparasitic, and antiprotozoal agents; · Anticancer classical and targeted chemotherapeutic agents, biological agents, hormonal drugs, immunomodulatory drugs, cell therapy and gene therapy; · Pharmacokinetic and pharmacodynamic properties of antimicrobial and anticancer agents; · The efficacy, safety and toxicology profiles of antimicrobial and anticancer drugs; · Drug interactions in single or combined applications; · Drug resistance to antimicrobial and anticancer drugs; · Research and development of novel antimicrobial and anticancer drugs, including preclinical, translational and clinical research; · Biomarkers of sensitivity and/or resistance for antimicrobial and anticancer drugs; · Pharmacogenetics and pharmacogenomics; · Precision medicine in infectious disease therapy and in cancer therapy; · Pharmacoeconomics of antimicrobial and anticancer therapies and the implications to patients, health services, and the pharmaceutical industry.

Topics Covered (Recognized by AI)

Biology93.6%Medicine88.8%Genetics87.9%Chemistry76.2%Biochemistry69.2%Internal medicine63.1%Microbiology61.9%Antibiotics53.1%Geology50.5%Paleontology50.4%Bacteria47.9%Surgery42.6%Pathology34.5%Organic chemistry34.2%Immunology26.3%Pharmacology22.5%Gene20.3%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank95/141

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank236/333

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank240/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank92/141

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank210/333

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank218/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	95/141	Q3
ONCOLOGY	JCRSCIE	236/333	Q3
PHARMACOLOGY & PHARMACY	JCRSCIE	240/356	Q3
INFECTIOUS DISEASES	JCISCIE	92/141	Q3
ONCOLOGY	JCISCIE	210/333	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	218/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year44

Total Citations6

2025

IF1.8

Articles / Year75

Total Citations95

2024

IF1.9

Articles / Year95

Total Citations394

2023

IF1.8

Articles / Year73

Total Citations341

2022

IF2.385

Articles / Year80

Total Citations604

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	44	6
2025	1.8	75	95
2024	1.9	95	394
2023	1.8	73	341
2022	2.385	80	604
2021	1.714	84	770
2020	1.661	86	988
2019	1.599	61	838
2018	1.49	40	559
2017	—	51	1,227
2016	—	62	684
2015	—	83	1,268

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,349Scopus Q3SCImago Profile

Scopus Coverage:1989-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.525

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

2.07

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,876 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations438

3-Year Documents221

Citable Documents210

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ3

Medicine (miscellaneous)Q3

OncologyQ3

PharmacologyQ3

Pharmacology (medical)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Chemotherapy (acronym: joc, abbr: J. Chemother, ISSN: 1120-009X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Maney Publishing in Italy since 1989. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.525 (Q3), an H-index of 60.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 74 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,876 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.